Drug: viramune Quarter: 2016Q3
Total Records: 153 Number of Pages: 8
| DRUGNAME | PT | EventCount |
|---|---|---|
| VIRAMUNE | Lipodystrophy acquired | 1 |
| VIRAMUNE | Liver function test increased | 1 |
| VIRAMUNE | Mean cell volume increased | 1 |
| VIRAMUNE | Metrorrhagia | 1 |
| VIRAMUNE | Mitochondrial toxicity | 1 |
| VIRAMUNE | Myocardial ischaemia | 1 |
| VIRAMUNE | Neural tube defect | 1 |
| VIRAMUNE | Non-cirrhotic portal hypertension | 1 |
| VIRAMUNE | Oesophagitis | 1 |
| VIRAMUNE | Oligohydramnios | 1 |
| VIRAMUNE | Pre-eclampsia | 1 |
| VIRAMUNE | Premature labour | 1 |
| VIRAMUNE | Progressive external ophthalmoplegia | 1 |
| VIRAMUNE | Pulmonary embolism | 1 |
| VIRAMUNE | Rash | 1 |
| VIRAMUNE | Regurgitation | 1 |
| VIRAMUNE | Restlessness | 1 |
| VIRAMUNE | Rhinitis | 1 |
| VIRAMUNE | Sclerotherapy | 1 |
| VIRAMUNE | Splenomegaly | 1 |
Total Records: 153 Number of Pages: 8